December 19, 2016 / 9:48 PM / 7 months ago

BRIEF-Foundation Medicine receives FDA approval of Foundationfocus

1 Min Read

Dec 19 (Reuters) - Foundation Medicine Inc

* Foundation Medicine receives FDA approval of Foundationfocus CDXBRCA as a companion diagnostic for Rubraca(Rucaparib) for the treatment of women with ovarian cancer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below